Published in Am J Health Syst Pharm on August 01, 2008
Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS. Kidney Int (2013) 0.89
Atomic description of the immune complex involved in heparin-induced thrombocytopenia. Nat Commun (2015) 0.78
Vitamin K intake, body mass index and warfarin maintenance dose. Cardiology (2013) 0.77
American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy (2006) 9.72
Addressing competencies for the future in the professional curriculum. Am J Pharm Educ (2009) 4.30
Optimizing antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndrome. Am J Health Syst Pharm (2008) 1.41
The diabetes epidemic: can we stop the spread? Pharmacotherapy (2003) 1.39
Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother (2006) 1.17
Best practice strategies for effective use of questions as a teaching tool. Am J Pharm Educ (2013) 1.14
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. Curr Med Res Opin (2010) 1.12
Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J Ethnopharmacol (2011) 1.12
The impact of advanced pharmacy practice experiences on students' readiness for self-directed learning. Am J Pharm Educ (2009) 1.12
Adherence and dosing frequency of common medications for cardiovascular patients. Am J Manag Care (2012) 1.06
White paper: value of specialty certification in pharmacy. J Am Pharm Assoc (2003) (2004) 0.95
Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps. J Am Pharm Assoc (2003) (2009) 0.92
Type 2 diabetes mellitus and heart failure. Pharmacotherapy (2008) 0.85
Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications. Drugs (2014) 0.83
Traditional management of chronic stable angina. Pharmacotherapy (2007) 0.83
Prevention of venous thromboembolism in acute medical illness. Pharmacotherapy (2002) 0.82
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature. Pharmacotherapy (2006) 0.82
Acute myocardial infarction induced by ephedrine alkaloids. Pharmacotherapy (2003) 0.81
Scoring objective structured clinical examinations using video monitors or video recordings. Am J Pharm Educ (2010) 0.81
Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy (2013) 0.80
Key articles and guidelines for the prevention of venous thromboembolism. Pharmacotherapy (2009) 0.79
Dosing of unfractionated heparin in acute coronary syndromes. Pharmacotherapy (2004) 0.79
Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm (2010) 0.78
Clopidogrel versus prasugrel: times are changing, but not for everyone. Pharmacotherapy (2009) 0.78
Anti-inflammatory effects of rosuvastatin in healthy subjects: a prospective longitudinal study. Curr Pharm Des (2014) 0.78
The role of intravenous dihydropyridine calcium channel blockers in the perioperative management of patients undergoing coronary artery bypass surgery. Curr Vasc Pharmacol (2008) 0.76
New pharmacologic methods to prevent venous thromboembolism in older adults: a meta-analysis. Ann Pharmacother (2013) 0.75
Case presentation: a patient with type 2 diabetes. Diabetes Educ (2007) 0.75
Multidisciplinary interventions: mapping new horizons in diabetes care. Diabetes Educ (2008) 0.75
Potential unrecognised costs of clopidogrel pretreatment in acute coronary syndrome. J Med Econ (2009) 0.75
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol (2017) 0.75
Cangrelor for treatment during percutaneous coronary intervention. Future Cardiol (2014) 0.75
Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach. Ann Pharmacother (2006) 0.75
Cardiovascular risks of cyclooxygenase inhibition. Pharmacotherapy (2006) 0.75
Beliefs and behaviors of professionally engaged pharmacists. J Am Pharm Assoc (2003) (2016) 0.75
Improved Learning Outcomes After Flipping a Therapeutics Module: Results of a Controlled Trial. Acad Med (2017) 0.75
Developing a business-practice model for pharmacy services in ambulatory settings. Pharmacotherapy (2008) 0.75
Improving the use of anticoagulant therapies in acutely ill medical patients. Am J Health Syst Pharm (2008) 0.75
ASHP Therapeutic Position Statement on the Treatment of Hypertension. Am J Health Syst Pharm (2006) 0.75